Skip to main content

A Bibliometric Analysis and Visualization of Current Research Trends in Chinese Medicine for Osteosarcoma

Abstract

Background

To illustrate the research framework, overall knowledge structure, and development trends of Chinese medicine (CM) treatment for osteosarcoma (OS) by using a bibliometric analysis and newly developed visualization tools.

Methods

Research datasets were acquired from the Web of Science (WOS) database from January 1, 1980 to September 30, 2019. VOS viewer and Citespace software was used to analyze the data and generate visualization knowledge maps. Annual trends of publications, distribution of institutes, distribution of journals, citation and H-index status, co-authorship status, research hotspots and co-citation status were analyzed.

Results

A total of 223 publications in the WOS database met the requirement. The number of published articles showed a rise but the citation frequency and the H-index of China were relatively low. The cooperation between the countries, institutes and authors were relatively weak. Most publications were basic researches. Most of the previous researches focused on basic mechanisms of CM in treating OS, and therapy and improvement of dosage form may become a frontier in this research field.

Conclusions

Compared with other fields, the field of CM treatment for osteosarcome is still in infancy. The distribution of researches is imbalanced and cooperation between countries, institutions and authors remains to be strengthened. Furthermore, basic research occupies an absolute dominant position, and the exploration of the molecular mechanism of CM in preventing and treating OS may become a key point in the future.

This is a preview of subscription content, access via your institution.

References

  1. Wang W, Hu S, Chang J, Ruan H, Zhi W, Wang X, et al. Down-regulated microRNA-34a expression as a prognostic marker for poor osteosarcoma in mice: a systematic review and meta-analysis. J Cancer 2018;9:4179–4186.

    CAS  Article  Google Scholar 

  2. Tan GJS, Gerrand CH, Rankin KS. Blood-borne biomarkers of osteosarcoma: a systematic review. Pediatr Blood Cancer 2019;66:e27462.

    Article  Google Scholar 

  3. Tamura T, Suzuki K, Yasuda T, Nogami S, Watanabe K, Kanamori M, et al. Extraskeletal osteosarcoma arising in the subcutaneous tissue of the lower leg: a case report and literature review. Mol Clin Oncol 2018;9:287–292.

    PubMed  PubMed Central  Google Scholar 

  4. Fu Y, Yu W, Cai H, Lu A. Forecast of actin-binding proteins as the oncotarget in osteosarcoma—a review of mechanism, diagnosis and therapy. Oncol Targets Ther 2018;11:1553–1561.

    Article  Google Scholar 

  5. Chang JL, Wang WY, Li YM, Hu SP, Yao M, Cui XJ, et al. Chinese herbal medicine for osteosarcoma in the mouse: a systematic review and meta-analysis. Chin J Integr Med 2019;25:370–377.

    Article  Google Scholar 

  6. Yan XY, Yan ZS, Liu WC, Ding H, Qia SZ, Chen G, et al. External application of traditional Chinese medicine in the treatment of bone cancer pain: a meta-analysis. Supp Care Cancer 2016;24:11–17.

    Article  Google Scholar 

  7. Di Genova L, Perruccio K, Celani MG, Mastrodicasa E, Cantisani TA, Esposito S, et al. Chemotherapy-related encephalopathy with super-refractory status epilepticus in a child with osteosarcoma: a case report with a review of literature. Front Pharmacol 2019;10:963.

    Article  Google Scholar 

  8. Valderrama-Zurian JC, Castello-Cogollos L, Aleixandre-Benavent R. Trends in scientific research in insights into imaging: a bibliometric review. Insights Imaging 2019;10:79.

    Article  Google Scholar 

  9. Zhang TS, Qin HL, Wang T, Li HT, Li H, Xia SH, et al. Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic review. Springerplus 2015;4:776.

    Article  Google Scholar 

  10. Boyce R, Rosch R, Finlayson A, Handuleh D, Walhad SA, Whitwell S, et al. Use of a bibliometric literature review to assess medical research capacity in post-conflict and developing countries: Somaliland 1991–2013. Trop Med Int Health 2015;20:1507–1515.

    Article  Google Scholar 

  11. Sun J, Wang MH, Ho YS. A historical review and bibliometric analysis of research on estuary pollution. Mar Pollut Bull 2012;64:13–21.

    CAS  Article  Google Scholar 

  12. van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 2010;84:523–538.

    Article  Google Scholar 

  13. Fajardo-Ortiz D, Duran L, Moreno L, Ochoa H, Castano VM. Mapping knowledge translation and innovation processes in cancer drug development: the case of liposomal doxorubicin. J Transl Med 2014;12:227.

    Article  Google Scholar 

  14. Chen C, Hu Z, Liu S, Tseng H. Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace. Expert Opin Biol Ther 2012;12:593–608.

    Article  Google Scholar 

  15. Saleem A, Husheem M, Harkonen P, Pihlaja K. Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula retz. fruit. J Ethnopharmacol 2002;81:327–336.

    CAS  Article  Google Scholar 

  16. Li HY, Zhang J, Sun LL, Li BH, Gao HL, Xie T, et al. Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo study. Cell Death Dis 2015;6:e1604.

    CAS  Article  Google Scholar 

  17. He BC, Gao JL, Zhang BQ, Luo Q, Shi Q, Kim SH, et al. Tetrandrine inhibits Wnt/beta-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol Pharmacol 2011;79:211–219.

    CAS  Article  Google Scholar 

  18. Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer 2009;115:1531–1543.

    Article  Google Scholar 

  19. Ottaviani G, Jaffe N. The etiology of osteosarcoma. Cancer Treat Res 2009;152:15–32.

    Article  Google Scholar 

  20. Corbiere C, Liagre B, Bianchi A, Bordji K, Dauca M, Netter P, et al. Different contribution of apoptosis to the antiproliferative effects of diosgenin and other plant steroids, hecogenin and tigogenin, on human 1547 osteosarcoma cells. Int J Oncol 2003;22:899–905.

    CAS  PubMed  Google Scholar 

  21. Liu YH, Wang SQ, Xue JH, Liu Y, Chen JY, Li GF, et al. Hundred top-cited articles focusing on acute kidney injury: a bibliometric analysis. BMJ Open 2016;6:e011630.

    Article  Google Scholar 

  22. Allen L, Jones C, Dolby K, Lynn D, Walport M. Looking for landmarks: the role of expert review and bibliometric analysis in evaluating scientific publication outputs. PLoS One 2009;4:e5910.

    Article  Google Scholar 

  23. Zhang QH, Hu QX, Xie D, Chang B, Miao HG, Wang YG, et al. Ganoderma lucidum exerts an anticancer effect on human osteosarcoma cells via suppressing the Wnt/beta-catenin signaling pathway. Integr Cancer Ther 2019;18:1534735419890917.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Tan T, Chen J, Hu Y, Wang N, Chen Y, Yu T, et al. Dihydrotanshinone I inhibits the growth of osteosarcoma through the Wnt/beta-catenin signaling pathway. Oncol Targets Ther 2019;12:5111–5122.

    CAS  Article  Google Scholar 

  25. Yao N, Ren K, Wang Y, Jin Q, Lu X, Lu Y, et al. Paris polyphylla suppresses proliferation and vasculogenic mimicry of human osteosarcoma cells and inhibits tumor growth in vivo. Am J Chin Med 2017;45:575–598.

    Article  Google Scholar 

  26. Qin J, Wang W, Sha L, Ge L. Huangqi Fuzheng Decoction exerts antitumor activity by inhibiting cell growth and inducing cell death in osteosarcoma. Biomed Pharmacother 2019;114:108854.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Wen Mo.

Additional information

Supported by the National Science Foundation of China (No. 81704097), “Sailing Program” of the Shanghai Science and Technology Committee (No. 19YF1449600), and the “Yumiao Project” of Longhua Hospital affiliated to Shanghai University of Chinese Medicine (No. LYTD-60)

Conflict of Interest

The authors declare that they have no competing interests.

Author Contributions

Yin MC, Wang HS and Yang X contributed to the design. Yan YJ and Fan ZX collected the studies. Yin MC, Xin CQ and Wang T drafted the manuscript. Ye J and Ma JM participated in the statistical analysis. Mo W revised the manuscript. All authors read and approved the final manuscript.

Availability of Data and Material

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Electronic supplementary material

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yin, Mc., Wang, Hs., Yang, X. et al. A Bibliometric Analysis and Visualization of Current Research Trends in Chinese Medicine for Osteosarcoma. Chin. J. Integr. Med. (2020). https://doi.org/10.1007/s11655-020-3429-4

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11655-020-3429-4

Keywords

  • osteosarcoma
  • Chinese medicine
  • bibliometric analysis
  • visualization
  • research trends